|
REPL Replimune Group Inc 1737953 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-313,940,000.00 |
| Balance Sheet |
|
Current Assets
|
$279,119,000.00 |
|
Assets
|
$332,388,000.00 |
|
Current Liabilities
|
$58,228,000.00 |
|
Liabilities
|
$166,228,000.00 |
|
Equity
|
$166,160,000.00 |
|
Shares Out
|
82716923.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-280,344,000.00 |
|
Investing Cash Flow
|
$310,843,000.00 |
| Market Analysis |
Market Cap
|
$447,498,553.43 |
|
Price
|
$10.38 |
|
BVPS
|
2.01 |
|
PB
|
2.69 |
|
EPS
|
-3.38 |
|
FCF
|
$-284,567,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-03 |
-0.77 |
|
| Jul |
Aug |
Sep |
| 2026-06-29 |
-3.38 |
|
|
2025-08-07 |
-0.95 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.90 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view REPL documents filed with the SEC.
REPL Filings
Clear
